author_facet Heitzer, Thomas
Brockhoff, Carsten
Mayer, Bernd
Warnholtz, Ascan
Mollnau, Hanke
Henne, Simone
Meinertz, Thomas
Münzel, Thomas
Heitzer, Thomas
Brockhoff, Carsten
Mayer, Bernd
Warnholtz, Ascan
Mollnau, Hanke
Henne, Simone
Meinertz, Thomas
Münzel, Thomas
author Heitzer, Thomas
Brockhoff, Carsten
Mayer, Bernd
Warnholtz, Ascan
Mollnau, Hanke
Henne, Simone
Meinertz, Thomas
Münzel, Thomas
spellingShingle Heitzer, Thomas
Brockhoff, Carsten
Mayer, Bernd
Warnholtz, Ascan
Mollnau, Hanke
Henne, Simone
Meinertz, Thomas
Münzel, Thomas
Circulation Research
Tetrahydrobiopterin Improves Endothelium-Dependent Vasodilation in Chronic Smokers : Evidence for a Dysfunctional Nitric Oxide Synthase
Cardiology and Cardiovascular Medicine
Physiology
author_sort heitzer, thomas
spelling Heitzer, Thomas Brockhoff, Carsten Mayer, Bernd Warnholtz, Ascan Mollnau, Hanke Henne, Simone Meinertz, Thomas Münzel, Thomas 0009-7330 1524-4571 Ovid Technologies (Wolters Kluwer Health) Cardiology and Cardiovascular Medicine Physiology http://dx.doi.org/10.1161/01.res.86.2.e36 <jats:p> <jats:italic>Abstract</jats:italic> —Conditions associated with impaired nitric oxide (NO) activity and accelerated atherosclerosis have been shown to be associated with a reduced bioavailability of tetrahydrobiopterin (BH4). We therefore hypothesized that BH4 supplementation may improve endothelial dysfunction of chronic smokers. Forearm blood flow (FBF) responses to the endothelium-dependent vasodilators acetylcholine (ACh; 0.75, 1.5, and 3.0 μg/100 mL tissue/min) or serotonin (5-HT; 0.7, 2.1, and 6.3 ng/100 mL tissue/min), to the inhibitor of endothelial nitric oxide synthase (NOS) <jats:italic>N</jats:italic> <jats:sup>G</jats:sup> -monomethyl- <jats:sc>l</jats:sc> -arginine (L-NMMA; 2, 4, and 8 μmol/min), and to the endothelium-independent vasodilator sodium nitroprusside (SNP; 0.1, 0.3, and 1.0 μg/100 mL tissue/min) were measured by venous occlusion plethysmography in controls and chronic smokers. Drugs were infused into the brachial artery, and FBF was measured before and during concomitant intra-arterial infusion of BH4, tetrahydroneopterin (NH4; another reduced pteridine), or the antioxidant vitamin C (6 and 18 mg/min). In control subjects, BH4 had no effect on FBF in response to ACh, 5-HT, and SNP. In contrast, in chronic smokers, the attenuated FBF responses to ACh and 5-HT were markedly improved by concomitant administration of BH4, whereas the vasodilator responses to SNP were not affected. L-NMMA-induced vasoconstriction was significantly reduced in smokers compared with controls, suggesting impaired basal NO bioactivity. BH4 improved L-NMMA responses in smokers while having no effect on L-NMMA responses in controls. Pretreatment with vitamin C abolished BH4 effects on ACh-dependent vasodilation. In vitro, NH4 scavenged superoxide created by the xanthine/xanthine oxidase reaction equipotent like BH4 but failed to modify ACh-induced changes in FBF in chronic smokers in vivo. These data support the concept that in addition to the free radical burden of cigarette smoke, a dysfunctional NOS III due to BH4 depletion may contribute at least in part to endothelial dysfunction in chronic smokers. The full text of this article is available at http://www.circresaha.org. </jats:p> Evidence for a Dysfunctional Nitric Oxide Synthase Tetrahydrobiopterin Improves Endothelium-Dependent Vasodilation in Chronic Smokers : Evidence for a Dysfunctional Nitric Oxide Synthase Circulation Research
doi_str_mv 10.1161/01.res.86.2.e36
facet_avail Online
Free
finc_class_facet Medizin
Biologie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE2MS8wMS5yZXMuODYuMi5lMzY
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE2MS8wMS5yZXMuODYuMi5lMzY
institution DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
imprint Ovid Technologies (Wolters Kluwer Health), 2000
imprint_str_mv Ovid Technologies (Wolters Kluwer Health), 2000
issn 0009-7330
1524-4571
issn_str_mv 0009-7330
1524-4571
language English
mega_collection Ovid Technologies (Wolters Kluwer Health) (CrossRef)
match_str heitzer2000tetrahydrobiopterinimprovesendotheliumdependentvasodilationinchronicsmokersevidenceforadysfunctionalnitricoxidesynthaseevidenceforadysfunctionalnitricoxidesynthase
publishDateSort 2000
publisher Ovid Technologies (Wolters Kluwer Health)
recordtype ai
record_format ai
series Circulation Research
source_id 49
title_sub Evidence for a Dysfunctional Nitric Oxide Synthase
title Tetrahydrobiopterin Improves Endothelium-Dependent Vasodilation in Chronic Smokers : Evidence for a Dysfunctional Nitric Oxide Synthase
title_unstemmed Tetrahydrobiopterin Improves Endothelium-Dependent Vasodilation in Chronic Smokers : Evidence for a Dysfunctional Nitric Oxide Synthase
title_full Tetrahydrobiopterin Improves Endothelium-Dependent Vasodilation in Chronic Smokers : Evidence for a Dysfunctional Nitric Oxide Synthase
title_fullStr Tetrahydrobiopterin Improves Endothelium-Dependent Vasodilation in Chronic Smokers : Evidence for a Dysfunctional Nitric Oxide Synthase
title_full_unstemmed Tetrahydrobiopterin Improves Endothelium-Dependent Vasodilation in Chronic Smokers : Evidence for a Dysfunctional Nitric Oxide Synthase
title_short Tetrahydrobiopterin Improves Endothelium-Dependent Vasodilation in Chronic Smokers : Evidence for a Dysfunctional Nitric Oxide Synthase
title_sort tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers : evidence for a dysfunctional nitric oxide synthase
topic Cardiology and Cardiovascular Medicine
Physiology
url http://dx.doi.org/10.1161/01.res.86.2.e36
publishDate 2000
physical
description <jats:p> <jats:italic>Abstract</jats:italic> —Conditions associated with impaired nitric oxide (NO) activity and accelerated atherosclerosis have been shown to be associated with a reduced bioavailability of tetrahydrobiopterin (BH4). We therefore hypothesized that BH4 supplementation may improve endothelial dysfunction of chronic smokers. Forearm blood flow (FBF) responses to the endothelium-dependent vasodilators acetylcholine (ACh; 0.75, 1.5, and 3.0 μg/100 mL tissue/min) or serotonin (5-HT; 0.7, 2.1, and 6.3 ng/100 mL tissue/min), to the inhibitor of endothelial nitric oxide synthase (NOS) <jats:italic>N</jats:italic> <jats:sup>G</jats:sup> -monomethyl- <jats:sc>l</jats:sc> -arginine (L-NMMA; 2, 4, and 8 μmol/min), and to the endothelium-independent vasodilator sodium nitroprusside (SNP; 0.1, 0.3, and 1.0 μg/100 mL tissue/min) were measured by venous occlusion plethysmography in controls and chronic smokers. Drugs were infused into the brachial artery, and FBF was measured before and during concomitant intra-arterial infusion of BH4, tetrahydroneopterin (NH4; another reduced pteridine), or the antioxidant vitamin C (6 and 18 mg/min). In control subjects, BH4 had no effect on FBF in response to ACh, 5-HT, and SNP. In contrast, in chronic smokers, the attenuated FBF responses to ACh and 5-HT were markedly improved by concomitant administration of BH4, whereas the vasodilator responses to SNP were not affected. L-NMMA-induced vasoconstriction was significantly reduced in smokers compared with controls, suggesting impaired basal NO bioactivity. BH4 improved L-NMMA responses in smokers while having no effect on L-NMMA responses in controls. Pretreatment with vitamin C abolished BH4 effects on ACh-dependent vasodilation. In vitro, NH4 scavenged superoxide created by the xanthine/xanthine oxidase reaction equipotent like BH4 but failed to modify ACh-induced changes in FBF in chronic smokers in vivo. These data support the concept that in addition to the free radical burden of cigarette smoke, a dysfunctional NOS III due to BH4 depletion may contribute at least in part to endothelial dysfunction in chronic smokers. The full text of this article is available at http://www.circresaha.org. </jats:p>
container_issue 2
container_start_page 0
container_title Circulation Research
container_volume 86
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792343627109761026
geogr_code not assigned
last_indexed 2024-03-01T16:54:41.378Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Tetrahydrobiopterin+Improves+Endothelium-Dependent+Vasodilation+in+Chronic+Smokers+%3A+Evidence+for+a+Dysfunctional+Nitric+Oxide+Synthase&rft.date=2000-02-04&genre=article&issn=1524-4571&volume=86&issue=2&jtitle=Circulation+Research&atitle=Tetrahydrobiopterin+Improves+Endothelium-Dependent+Vasodilation+in+Chronic+Smokers+%3A+Evidence+for+a+Dysfunctional+Nitric+Oxide+Synthase&aulast=Mu%CC%88nzel&aufirst=Thomas&rft_id=info%3Adoi%2F10.1161%2F01.res.86.2.e36&rft.language%5B0%5D=eng
SOLR
_version_ 1792343627109761026
author Heitzer, Thomas, Brockhoff, Carsten, Mayer, Bernd, Warnholtz, Ascan, Mollnau, Hanke, Henne, Simone, Meinertz, Thomas, Münzel, Thomas
author_facet Heitzer, Thomas, Brockhoff, Carsten, Mayer, Bernd, Warnholtz, Ascan, Mollnau, Hanke, Henne, Simone, Meinertz, Thomas, Münzel, Thomas, Heitzer, Thomas, Brockhoff, Carsten, Mayer, Bernd, Warnholtz, Ascan, Mollnau, Hanke, Henne, Simone, Meinertz, Thomas, Münzel, Thomas
author_sort heitzer, thomas
container_issue 2
container_start_page 0
container_title Circulation Research
container_volume 86
description <jats:p> <jats:italic>Abstract</jats:italic> —Conditions associated with impaired nitric oxide (NO) activity and accelerated atherosclerosis have been shown to be associated with a reduced bioavailability of tetrahydrobiopterin (BH4). We therefore hypothesized that BH4 supplementation may improve endothelial dysfunction of chronic smokers. Forearm blood flow (FBF) responses to the endothelium-dependent vasodilators acetylcholine (ACh; 0.75, 1.5, and 3.0 μg/100 mL tissue/min) or serotonin (5-HT; 0.7, 2.1, and 6.3 ng/100 mL tissue/min), to the inhibitor of endothelial nitric oxide synthase (NOS) <jats:italic>N</jats:italic> <jats:sup>G</jats:sup> -monomethyl- <jats:sc>l</jats:sc> -arginine (L-NMMA; 2, 4, and 8 μmol/min), and to the endothelium-independent vasodilator sodium nitroprusside (SNP; 0.1, 0.3, and 1.0 μg/100 mL tissue/min) were measured by venous occlusion plethysmography in controls and chronic smokers. Drugs were infused into the brachial artery, and FBF was measured before and during concomitant intra-arterial infusion of BH4, tetrahydroneopterin (NH4; another reduced pteridine), or the antioxidant vitamin C (6 and 18 mg/min). In control subjects, BH4 had no effect on FBF in response to ACh, 5-HT, and SNP. In contrast, in chronic smokers, the attenuated FBF responses to ACh and 5-HT were markedly improved by concomitant administration of BH4, whereas the vasodilator responses to SNP were not affected. L-NMMA-induced vasoconstriction was significantly reduced in smokers compared with controls, suggesting impaired basal NO bioactivity. BH4 improved L-NMMA responses in smokers while having no effect on L-NMMA responses in controls. Pretreatment with vitamin C abolished BH4 effects on ACh-dependent vasodilation. In vitro, NH4 scavenged superoxide created by the xanthine/xanthine oxidase reaction equipotent like BH4 but failed to modify ACh-induced changes in FBF in chronic smokers in vivo. These data support the concept that in addition to the free radical burden of cigarette smoke, a dysfunctional NOS III due to BH4 depletion may contribute at least in part to endothelial dysfunction in chronic smokers. The full text of this article is available at http://www.circresaha.org. </jats:p>
doi_str_mv 10.1161/01.res.86.2.e36
facet_avail Online, Free
finc_class_facet Medizin, Biologie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE2MS8wMS5yZXMuODYuMi5lMzY
imprint Ovid Technologies (Wolters Kluwer Health), 2000
imprint_str_mv Ovid Technologies (Wolters Kluwer Health), 2000
institution DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1
issn 0009-7330, 1524-4571
issn_str_mv 0009-7330, 1524-4571
language English
last_indexed 2024-03-01T16:54:41.378Z
match_str heitzer2000tetrahydrobiopterinimprovesendotheliumdependentvasodilationinchronicsmokersevidenceforadysfunctionalnitricoxidesynthaseevidenceforadysfunctionalnitricoxidesynthase
mega_collection Ovid Technologies (Wolters Kluwer Health) (CrossRef)
physical
publishDate 2000
publishDateSort 2000
publisher Ovid Technologies (Wolters Kluwer Health)
record_format ai
recordtype ai
series Circulation Research
source_id 49
spelling Heitzer, Thomas Brockhoff, Carsten Mayer, Bernd Warnholtz, Ascan Mollnau, Hanke Henne, Simone Meinertz, Thomas Münzel, Thomas 0009-7330 1524-4571 Ovid Technologies (Wolters Kluwer Health) Cardiology and Cardiovascular Medicine Physiology http://dx.doi.org/10.1161/01.res.86.2.e36 <jats:p> <jats:italic>Abstract</jats:italic> —Conditions associated with impaired nitric oxide (NO) activity and accelerated atherosclerosis have been shown to be associated with a reduced bioavailability of tetrahydrobiopterin (BH4). We therefore hypothesized that BH4 supplementation may improve endothelial dysfunction of chronic smokers. Forearm blood flow (FBF) responses to the endothelium-dependent vasodilators acetylcholine (ACh; 0.75, 1.5, and 3.0 μg/100 mL tissue/min) or serotonin (5-HT; 0.7, 2.1, and 6.3 ng/100 mL tissue/min), to the inhibitor of endothelial nitric oxide synthase (NOS) <jats:italic>N</jats:italic> <jats:sup>G</jats:sup> -monomethyl- <jats:sc>l</jats:sc> -arginine (L-NMMA; 2, 4, and 8 μmol/min), and to the endothelium-independent vasodilator sodium nitroprusside (SNP; 0.1, 0.3, and 1.0 μg/100 mL tissue/min) were measured by venous occlusion plethysmography in controls and chronic smokers. Drugs were infused into the brachial artery, and FBF was measured before and during concomitant intra-arterial infusion of BH4, tetrahydroneopterin (NH4; another reduced pteridine), or the antioxidant vitamin C (6 and 18 mg/min). In control subjects, BH4 had no effect on FBF in response to ACh, 5-HT, and SNP. In contrast, in chronic smokers, the attenuated FBF responses to ACh and 5-HT were markedly improved by concomitant administration of BH4, whereas the vasodilator responses to SNP were not affected. L-NMMA-induced vasoconstriction was significantly reduced in smokers compared with controls, suggesting impaired basal NO bioactivity. BH4 improved L-NMMA responses in smokers while having no effect on L-NMMA responses in controls. Pretreatment with vitamin C abolished BH4 effects on ACh-dependent vasodilation. In vitro, NH4 scavenged superoxide created by the xanthine/xanthine oxidase reaction equipotent like BH4 but failed to modify ACh-induced changes in FBF in chronic smokers in vivo. These data support the concept that in addition to the free radical burden of cigarette smoke, a dysfunctional NOS III due to BH4 depletion may contribute at least in part to endothelial dysfunction in chronic smokers. The full text of this article is available at http://www.circresaha.org. </jats:p> Evidence for a Dysfunctional Nitric Oxide Synthase Tetrahydrobiopterin Improves Endothelium-Dependent Vasodilation in Chronic Smokers : Evidence for a Dysfunctional Nitric Oxide Synthase Circulation Research
spellingShingle Heitzer, Thomas, Brockhoff, Carsten, Mayer, Bernd, Warnholtz, Ascan, Mollnau, Hanke, Henne, Simone, Meinertz, Thomas, Münzel, Thomas, Circulation Research, Tetrahydrobiopterin Improves Endothelium-Dependent Vasodilation in Chronic Smokers : Evidence for a Dysfunctional Nitric Oxide Synthase, Cardiology and Cardiovascular Medicine, Physiology
title Tetrahydrobiopterin Improves Endothelium-Dependent Vasodilation in Chronic Smokers : Evidence for a Dysfunctional Nitric Oxide Synthase
title_full Tetrahydrobiopterin Improves Endothelium-Dependent Vasodilation in Chronic Smokers : Evidence for a Dysfunctional Nitric Oxide Synthase
title_fullStr Tetrahydrobiopterin Improves Endothelium-Dependent Vasodilation in Chronic Smokers : Evidence for a Dysfunctional Nitric Oxide Synthase
title_full_unstemmed Tetrahydrobiopterin Improves Endothelium-Dependent Vasodilation in Chronic Smokers : Evidence for a Dysfunctional Nitric Oxide Synthase
title_short Tetrahydrobiopterin Improves Endothelium-Dependent Vasodilation in Chronic Smokers : Evidence for a Dysfunctional Nitric Oxide Synthase
title_sort tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers : evidence for a dysfunctional nitric oxide synthase
title_sub Evidence for a Dysfunctional Nitric Oxide Synthase
title_unstemmed Tetrahydrobiopterin Improves Endothelium-Dependent Vasodilation in Chronic Smokers : Evidence for a Dysfunctional Nitric Oxide Synthase
topic Cardiology and Cardiovascular Medicine, Physiology
url http://dx.doi.org/10.1161/01.res.86.2.e36